Aether Industries and Dow Chemical International Private Limited (Dow India) launched a collaborative research program on July 31, 2026, to develop new manufacturing technologies for silicones. This partnership aims to create indigenous technology for high-performance materials used in construction, mobility, electronics, healthcare, and personal care. By establishing a framework for long-term strategic partnership, the companies seek to potentially commercialize and industrially scale the technologies developed through the program, addressing India's expanding demand for advanced materials.

The announcement was made under Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. All research and pilot-scale development will be executed jointly by the two companies at Aether’s R&D and pilot facilities in Surat, Gujarat. Dr. Aman Desai, Co-Founder and Director of Research and Operations at Aether Industries, stated that Dow has chosen Aether as its exclusive research partner for this pioneering program. He noted that the collaboration combines Aether's core chemistry competencies with Dow's global leadership in silicone applications.

Key Details of the Collaboration

Brendy Lange, President of Dow Performance Materials & Coatings, said the collaboration strengthens Dow's ability to bring materials science innovation closer to high-growth markets. Dr. Mukund Parthasarathy, Business Vice President of R&D at Dow Performance Materials & Coatings, added that the approach allows faster movement from science to scalable technologies. Siddhartha Ghosal, Country President of Dow India, highlighted that India's growing demand for advanced materials presents a strong opportunity to develop differentiated technologies closer to the market. He emphasized that the program brings together strengths to create value for customers and support local innovation.

What the Numbers Show

While specific financial figures for the collaboration were not disclosed, the strategic alignment indicates a significant shift towards localized R&D capabilities in India. By leveraging Aether's existing infrastructure in Surat, Dow reduces the time-to-market for new silicone solutions. The exclusivity of Aether as the research partner suggests a deep integration of technical resources, potentially lowering development costs and accelerating the path from pilot scale to industrial manufacture. This model contrasts with traditional offshore R&D structures, positioning India as a hub for specialized chemical innovation rather than just a manufacturing base.

Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE0BWX01014/3850d0ee74044aec.pdf

Aether Industries reported a consolidated net profit of ₹627.49 million for the first quarter ended June 30, 2026 (Q1FY27), marking a 33.6% year-on-year increase from ₹470.21 million in the corresponding period of the previous year. The specialty chemicals manufacturer saw its revenue from operations grow by 27.2% to ₹3,265.57 million, driven by robust demand in Contract Exclusive Manufacturing (CEM) and Large Scale Manufacturing (LSM). This growth trajectory underscores the company’s successful shift towards higher-margin business models, which has supported stable EBITDA margins despite volume fluctuations in specific segments.

The Board of Directors approved the unaudited standalone and consolidated financial results during a meeting held on July 31, 2026, pursuant to Regulation 30 and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The results were subjected to a limited review by the statutory auditors, Suresh I Surana & Associates, who issued an unmodified conclusion.

Financial Performance Overview

The company's top-line expansion was primarily fueled by higher revenue from operations, which increased from ₹2,566.29 million in Q1FY26 to ₹3,265.57 million in Q1FY27. Total income rose to ₹3,342.46 million from ₹2,587.09 million year-ago. Other income also contributed significantly, jumping to ₹76.89 million from ₹20.80 million in the prior year's first quarter.

Profit before tax stood at ₹834.53 million, up from ₹616.26 million previously. After accounting for total tax expenses of ₹207.04 million, the net profit attributable to owners reached ₹627.49 million. Earnings per share (basic) were reported at ₹4.77, an increase from ₹3.55 in Q1FY26.

The following table summarises the key consolidated financial metrics for the quarter:

Note: EBITDA figures are derived from management commentary; exact EBITDA line item not explicitly separated in the provided P&L table but referenced in existing analysis.

Segment Mix and Revenue Drivers

Revenue by business model in Q1FY27 was dominated by Contract Exclusive Manufacturing (CEM), which contributed 51.5% (₹1,656 million), followed by Large Scale Manufacturing (LSM) at 39.1% (₹1,258 million), and Contract Research & Manufacturing Services (CRAMS) at 9.3% (₹301 million). Regionally, domestic sales accounted for 62.5% of revenue, while exports, including deemed exports and SEZ sales, made up 37.5%.

By end-use sector, Pharma remained the largest contributor at 32.2%, followed by Oil & Gas at 31.4%. Material Science contributed 16.6%, while Agro accounted for 9.5%. The company noted that Oil & Gas and Material Science are expected to be main drivers despite new product launches in Pharmaceuticals and Agrochemicals.

Operational Milestones and Corporate Actions

Aether Industries spent ₹198.07 million on Research & Development in Q1FY27, accounting for 6.16% of revenues. Key operational highlights include:

• Site 5 Phase One: Two production blocks commenced commercial operation in Q1FY27, with revenue contribution expected from Q2FY27 onwards.
• Site 3++: Commercial production started with ramp-up ongoing.
• Customer Acquisition: 10 new customers were onboarded across all business models during Q1FY27.

During the same meeting, the Board approved several strategic actions:

• Director Re-appointments: Ashwin Desai as Managing Director, and Purnima Desai, Rohan Desai, and Aman Desai as Whole-time Directors, each for a five-year term effective October 1, 2026, subject to shareholder approval.
• Auditor Appointments: CA Riddhi Chitaliya as Internal Auditor, and M/s. PAAA & Associates as Cost Auditor for FY2027.
• Senior Managerial Personnel: Designation of six employees including Denish Dodhiyawala and Parag Detroja as Senior Managerial Personnel effective August 1, 2026.
• AGM Notice: The 14th AGM is scheduled for September 11, 2026, via video conferencing.

Insurance Settlements and Material Disclosures

A material factor influencing the current quarter's results was the settlement of an insurance claim stemming from a fire at Manufacturing Facility-II in November 2023. During Q1FY27, the insurance company paid a balance settlement of ₹260.05 million, comprising ₹225.05 million for asset loss and ₹35.00 million for financial loss/profit (FLOP). The company had previously written off damaged property amounting to ₹299.68 million during the quarter ended March 31, 2026.

Additionally, the company recognized a loss of ₹70.00 million in the previous fiscal year due to a fire at an external warehouse in March 2026. An insurance claim for this incident is currently under assessment, with any recovery to be recognized upon reasonable certainty of receipt.

What the Numbers Show

The shift in business model towards higher-margin CEM and CRAMS contracts is clearly reflected in the financials. While LSM revenue declined slightly from ₹1,325 million in Q1FY26 to ₹1,258 million in Q1FY27, CEM revenue surged by 75% to ₹1,656 million. This mix shift, combined with price-led demand in LSM, has supported stable EBITDA margins at 31% despite volume fluctuations in specific segments. The significant R&D spend (6.16% of revenue) indicates continued investment in innovation, which management expects to drive future growth through new product launches and customer acquisitions.